title: Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONAEII survey.
abstract: Inflammatory bowel disease (IBD) units have a relevant weight within gastroenterology departments. In order to gain insight into the managerial aspects of IBD diagnosis and treatment, SEPD submitted a survey (GESTIONAEII) to department heads, IBD specialists, and other gastroenterologists. In this letter, we discuss the results obtained from gastroenterology department heads.
authors.affiliation: Digestivo, H. Universitarioa Virgen Macarena, España.
authors.forename: Federico
authors.initials: F
authors.lastname: Argüelles Arias
authors.affiliation: Digestivo, Hospital Universitario de Santiago de Compostela.
authors.forename: Manuel
authors.initials: M
authors.lastname: Barreiro-de Acosta
authors.affiliation: Aparato Digestivo, Hospital de Manises.
authors.forename: Joaquín
authors.initials: J
authors.lastname: Hinojosa
mesh_terms: D016527:Drug Costs; D019538:Health Care Surveys; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000191:economics*; D013030:Spain